35results about Sunitinib malate companies
Sort by:
Most relevant
The orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells. Check for http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=299061&idtype=1 active clinical trials or http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=299061&idtype=1&closed=1 closed clinical trials using this agent. (http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C26673 NCI Thesaurus)
1981
|
United Kingdom
|
-
|
http://mylan.co.uk
|
Subsidiary Company
Generics (U.K.) Ltd. manufactures generic pharmaceutical products. It makes generic drugs which includes acid reflux remedy Pepcid, antibiotic Cipro and allergy treatment Zyrtec. The firm also manufactures cytotoxics such as azathioprine and penicillin based antibiotics. The company was founded on April 29, 1981 and is headquartered in Potters Bar, the United Kingdom.
More
|
Slovenia
|
-
|
http://www.lek.si
|
Subsidiary Company
Lek Pharmaceuticals dd, a subsidiary of Novartis AG, is a company headquartered in Ljubljana, Slovenia, that develops, manufactures and markets drugs and pharmaceutical products. Robert Ljoljo is the CEO, in this role since 2019. On November 21, 2002 Novartis AG acquired Lek Pharmaceuticals dd for $689.24 million.
More
1901
|
Israel
|
10,000-50,000
|
http://www.teva.co.il
|
Public Company
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
More
1849
|
United States
|
50,000-100,000
|
http://www.pfizer.com
|
Public Company
Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.
More
|
United States
|
-
|
-
|
Private Company
More
1972
|
Spain
|
500-1,000
|
http://www.medichem.es
|
Holding Company
Medichem SA is a Spanish company located in Sant Joan Despi that manufactures and supplies pharmaceutical ingredients. The firm was founded in 1972. José Luis Rodríguez is the CEO, in this role since 1996.
More
Contract research organization
Travatan Z
Cardiovascular agent
...[+15]
1985
|
United States
|
-
|
http://www.tevausa.com
|
Subsidiary Company
Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.
More
1995
|
China
|
-
|
http://www.hansoh.cn
|
Subsidiary Company
Part of Hansoh Pharmaceutical Group Co., Ltd., Jiangsu Hansoh Pharmaceutical Co. Ltd. is a company headquartered in Jiangsu, China, that manufactures and distributes pharmaceutical products.
More
1995
|
India
|
1,000-5,000
|
http://www.indswiftlabs.com
|
Public Company
Ind-Swift Laboratories Ltd. engages in the manufacture, development, and market of pharmaceutical ingredients. The firm operates through In India and Outside India geographical segments. Its products include API's and impurities. The firm supplies active pharmaceutical ingredients to pharmaceutical companies and also provides research and development services. The company was founded on January 4, 1995 and is headquartered in Manimajra, India.
More
Contract research organization
2000
|
Germany
|
50-100
|
http://www.immatics.com
|
immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors.
The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors.
immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.
More
1984
|
China
|
-
|
http://english.zryhyy.com.cn
|
Private Company
The China-Japan Friendship Hospital (Chinese: 中日友好医院) was established through the cooperation of the Chinese and Japanese governments during the 1980s. The hospital has been directly affiliated with China's Ministry of Health since its first day of operation, October 23, 1984. The hospital is located on East Yinghuayuan Street, Chaoyang District, Beijing. The hospital covers 9.7 hectares, with floorspace of facilities measuring 180,000 square meters. Within the hospital, there are 1,500 beds, 58 departments, as well as a clinical research and education center. The hospital has intensive care and treatment of severe diseases as a primary focus and integrative eastern-western medicinal therapy as an additional area of expertise. The hospital often attends to the health care of senior officials from over 100 countries and regions.
More
1996
|
Italy
|
-
|
http://www.sicor-sureco.it
|
Private Company
Manufactures and develops pharmaceutical products
More
2001
|
China
|
-
|
-
|
Subsidiary Company
Shenlong (Kunshan) Biochemical Technology Co., Ltd., established on 2001-02-13, The scope of business includes the establishment of a research center,develop new drugs,New manufacturing process of raw materials,Formulation,Pharmaceutical Technology,And provide consulting services such as biotechnology research and development;engaged in pharmaceutical raw materials,Pharmaceutical Intermediates,Fine Chemicals,Biochemicals,chemical reagent(medicine,Precursor chemicals and hazardous chemicals are excluded)commercial wholesale,commission agent(except auction)and import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)
More
2014
|
China
|
-
|
http://www.xkypharm.com
|
Private Company
Beijing Xinkaiyuan Pharmaceutical Technology Co., Ltd., established on 2014-03-20, Business scope includes biotechnology promotion;Medical Research;technology development;technical consulting;technology transfer;Import and export,Technology Import and Export,Agent import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)
More
2003
|
China
|
-
|
https://www.dyg.cn
|
Subsidiary Company
Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.
More
1991
|
Netherlands
|
1,000-5,000
|
http://www.synthon.com
|
Subsidiary Company
Good health and a happy life is something all people rightly aspire to. They believe everyone on the planet deserves access to quality health care.
Finding affordable solutions to today's health care challenges demands cutting-edge science, highly talented and motivated people and above all the ability to innovate. Innovation and continuous improvement are the heartbeat of their company.
Their mission is to make health care more affordable, increasing access to important medicines through the provision of high quality small molecule generics, and new biological and new chemical entities.
More
Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
1998
|
China
|
-
|
http://www.acebright.com
|
Private Company
Shanghai Acrono Pharmaceutical Group Co., Ltd., established on 1998-08-14, Business scope includes research and development of pharmaceutical products and biotechnology products,Pilot test for R&D projects,Transfer of self-owned R&D results,Provide relevant technical support and technical services,Import and export of goods and technology(without distribution)business.
[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]
More
2000
|
China
|
-
|
http://www.huawe.com
|
Subsidiary Company
Nanjing Huawe Medicine Technology Development Co., Ltd. engages in the research and development, and manufacture of medicine and active pharmaceutical ingredient products. It offers anti-tumor, anti-infection, diabetes, hypertension, and anti-gout medicines. The company was founded on June 30, 2000 and is headquartered in Nanjing, China.
More
2011
|
South Korea
|
-
|
http://www.samyangbiopharm.com
|
Subsidiary Company
Samyang Biopharmaceuticals Corp. wholesales medical supplies and other medicine-related products. The company was founded on November 1, 2011 and is headquartered in Seongnam, South Korea.
More
2004
|
China
|
-
|
-
|
Private Company
Jiangsu Xidi Pharmaceutical Co., Ltd., established on 2004-06-29, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)
General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)
More
Login to view more
People also interested in
Keywords Quick Entry
Coronary heart diseaseDigestive tractDithizoneMechanical rectifierTransmission illuminationACETONE/ALCOHOLCdna copyIsononyl alcoholInstalled basePlacement actionTumor imagingGradient generatorUrine odorSensitivity testingPulmonary arteryMorningAdenovirus genomePulse beamMri imageDrugs problemsDirectivity patternLocation intelligenceBypass operationGeomembraneUrban transportationVelocity measurementDome shapeAmplitude demodulationAgaraseWater concentration
View more
Page generation time: